In a major boost for Nigeria’s health sector, the European Union (EU), France, and the Federal Government of Nigeria have signed a €10.2 million partnership agreement aimed at strengthening local medicine production and advancing the nation’s pharmaceutical industry.
According to a statement issued by the EU on Friday, the initiative seeks to improve Nigeria’s pharmaceutical manufacturing capacity, promote self-sufficiency in essential drugs, and enhance public health resilience across the country.
The partnership, officials noted, aligns with Nigeria’s commitment to reducing dependence on imported medicines while ensuring the availability of quality, affordable drugs for millions of citizens.
The program will also support technology transfer, regulatory reforms, and workforce training within the pharmaceutical value chain — a step seen as critical to achieving sustainable healthcare delivery and industrial growth.
This collaboration reflects the EU’s broader agenda of supporting Africa’s health sovereignty and deepening development cooperation with Nigeria through innovation, investment, and capacity building.